Cargando…

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light

BACKGROUND: The INTERCEPT Blood System pathogen reduction technology (PRT), which uses amotosalen and ultraviolet A light treatment (amotosalen/UV‐PRT), inactivates pathogens in plasma and platelet components (PCs). This review summarizes data describing the inactivation efficacy of amotosalen/UVA‐P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanteri, Marion C., Santa‐Maria, Felicia, Laughhunn, Andrew, Girard, Yvette A., Picard‐Maureau, Marcus, Payrat, Jean‐Marc, Irsch, Johannes, Stassinopoulos, Adonis, Bringmann, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317863/ https://www.ncbi.nlm.nih.gov/pubmed/32333396 http://dx.doi.org/10.1111/trf.15807

Ejemplares similares

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020)

Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light
por: Infanti, Laura, et al.
Publicado: (2022)

Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies
por: Santa Maria, Felicia, et al.
Publicado: (2022)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units
por: Bubinski, Michal, et al.
Publicado: (2021)

Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light
por: Hindawi, S.I., et al.
Publicado: (2022)

Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
por: Kumar, Ankit, et al.
Publicado: (2022)

Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance
por: Stivala, Simona, et al.
Publicado: (2017)

Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination
por: Arnason, Niels Arni, et al.
Publicado: (2022)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation
por: Kleinman, Steve, et al.
Publicado: (2015)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma
por: Azhar, Esam I., et al.
Publicado: (2020)

SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment
por: Ferrari, Alessandro, et al.
Publicado: (2022)

Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015)

Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study
por: Christensen, Christian, et al.
Publicado: (2020)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
por: Keil, Shawn D., et al.
Publicado: (2020)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Experimental studies on the inactivation of HBV in blood via riboflavin photochemical treatment
por: Zhou, Zi-Yu, et al.
Publicado: (2017)

RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity
por: Green, Alex B., et al.
Publicado: (2023)

Evaluation of the inactivation effect of riboflavin photochemical method on duck hepatitis B virus
por: Zhou, Zi-Yu, et al.
Publicado: (2018)

Aluminum plasmonic nanoshielding in ultraviolet inactivation of bacteria
por: Kunz, Jeremy N., et al.
Publicado: (2017)

Site-Specific Photochemical Reaction for Improved C=C Location Analysis of Unsaturated Lipids by Ultraviolet Photodissociation
por: Li, Hai-Fang, et al.
Publicado: (2022)

Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs)
por: Rae, Chris, et al.
Publicado: (2008)

THE ULTRAVIOLET LIGHT AND PHOTOSENSITIZED INACTIVATION OF TOBACCO MOSAIC VIRUS
por: Oster, Gerald, et al.
Publicado: (1950)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide
por: Xuan, Weijun, et al.
Publicado: (2018)

PHOTOREACTIVATION IN VITRO OF ULTRAVIOLET INACTIVATED HEMOPHILUS INFLUENZAE TRANSFORMING FACTOR
por: Rupert, Claud S., et al.
Publicado: (1958)

Lagrangian modeling of inactivation of airborne microorganisms by in-duct ultraviolet lamps
por: Yang, Yi, et al.
Publicado: (2021)

Narrow-Band 311 nm Ultraviolet-B Radiation Evokes Different Antioxidant Responses from Broad-Band Ultraviolet
por: Rácz, Arnold, et al.
Publicado: (2021)

Photochemical internalization
por: Jerjes, Waseem, et al.
Publicado: (2010)

Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation
por: Mitchell, David, et al.
Publicado: (2010)

The characterization of upper-room ultraviolet germicidal irradiation in inactivating airborne microorganisms.
por: Ko, Gwangpyo, et al.
Publicado: (2002)

THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION
por: Salk, Jonas E., et al.
Publicado: (1940)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q48cjrp6p5j3psc105fncj7ces